OpGen Inc (NASDAQ:OPGN) was up 3.7% during trading on Thursday . The company traded as high as $0.29 and last traded at $0.28, approximately 3,761 shares changed hands during mid-day trading. A decline of 97% from the average daily volume of 145,143 shares. The stock had previously closed at $0.27.

A number of equities research analysts have commented on OPGN shares. Zacks Investment Research lowered OpGen from a “buy” rating to a “hold” rating in a research report on Tuesday, June 18th. ValuEngine upgraded OpGen from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Finally, HC Wainwright reiterated a “buy” rating and issued a $1.50 price target on shares of OpGen in a research report on Sunday, May 19th.

The company has a market capitalization of $4.75 million, a price-to-earnings ratio of -0.13 and a beta of 0.83. The company has a debt-to-equity ratio of 1.07, a quick ratio of 0.78 and a current ratio of 0.89. The business has a 50 day moving average price of $0.32 and a 200-day moving average price of $0.66.

Large investors have recently made changes to their positions in the company. Bank of New York Mellon Corp acquired a new position in shares of OpGen in the 4th quarter valued at about $27,000. Susquehanna International Group LLP acquired a new position in shares of OpGen in the 2nd quarter valued at about $28,000. Finally, Virtu Financial LLC acquired a new position in shares of OpGen in the 1st quarter valued at about $70,000. 10.31% of the stock is currently owned by institutional investors.

OpGen Company Profile (NASDAQ:OPGN)

OpGen, Inc, a precision medicine company, engages in developing molecular information products and services to combat infectious diseases in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms.

Further Reading: What is operating income?

Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.